Miromatrix Medical Inc.
MIRO · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | 2,783.5% | -28.9% | -81.4% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $0 |
| Gross Profit | $0 | -$0 | -$0 | $0 |
| % Margin | 47.6% | -1,412.1% | -974.6% | 0% |
| R&D Expenses | $18 | $11 | $7 | $6 |
| G&A Expenses | $9 | $5 | $2 | $2 |
| SG&A Expenses | $9 | $5 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $4 | $1 | -$1 | -$0 |
| Operating Expenses | $31 | $16 | $9 | $9 |
| Operating Income | -$30 | -$17 | -$10 | -$9 |
| % Margin | -3,172.2% | -51,289.9% | -22,047.2% | -3,596.7% |
| Other Income/Exp. Net | $0 | $2 | -$0 | -$1 |
| Pre-Tax Income | -$30 | -$15 | -$10 | -$10 |
| Tax Expense | $0 | $0 | -$2 | -$6 |
| Net Income | -$30 | -$15 | -$9 | -$3 |
| % Margin | -3,147.2% | -45,230% | -18,732.7% | -1,228.1% |
| EPS | -1.45 | -0.73 | -0.82 | -0.29 |
| % Growth | -98.6% | 11% | -182.8% | – |
| EPS Diluted | -1.45 | -0.73 | -0.82 | -0.29 |
| Weighted Avg Shares Out | 21 | 20 | 11 | 10 |
| Weighted Avg Shares Out Dil | 21 | 20 | 11 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $1 | $0 |
| Depreciation & Amortization | $0 | $0 | -$1 | -$0 |
| EBITDA | -$30 | -$14 | -$11 | -$9 |
| % Margin | -3,114.7% | -41,820.4% | -24,598.5% | -3,653.7% |